Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense

Oncology Letters

Volumn 6, Issue 4, 2013, Pages 1140-1146

  Chen, Yingli ^a,b   Zhou, Chunlan ^a   Ge, Zhendan ^a   Liu, Yufa ^c   Liu, Yuming ^d   Feng, Weiyi ^e   Li, Sen ^a   Chen, Guoyou ^a   Wei, Taiming ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Biopharmaceutical Institute of the Heilongjiang Academy of Medical Sciences   (China)

^c SHANDONG NORMAL UNIVERSITY   (China)

^d TIANJIN UNIVERSITY OF TECHNOLOGY   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Antiproliferative activity; Apoptosis; Essential oil; Frankincense; Gas chromatography mass spectrometry; Myrrh

Indexed keywords

2 CYCLOHEXENONE; 4 ETHYNYL 4 HYDROXY 3 5 5 TRIMETHYL; ALCOHOL; AROMADENDRENE; BETA ELEMENE; COPAENE; ESSENTIAL OIL; ESTER; FRANKINCENSE ESSENTIAL OIL; MYRRH ESSENTIAL OIL; N OCTYL ACETATE; OCTANOL; PINENE; PLANT RESIN; SESQUITERPENE; TERPENE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BOSWELLIA SACRA; CELL CULTURE; CELL STRAIN MCF 7; CHEMICAL COMPOSITION; COMMIPHORA PYRACANTHOIDES; DRUG POTENTIATION; HUMAN; HUMAN CELL; HYDRODISTILLATION; MASS FRAGMENTOGRAPHY; MEDICINAL PLANT; TUMOR CELL LINE;

EID: 84881584693     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1520     Document Type: Article

References (23)

1. Su S, Wang T, Duan JA, et al: Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. J Ethnopharmacol 134: 251-258, 2011.
2. Wu XS, Xie T, Lin J, et al: An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J Pharm Pharmacol 61: 1653-1656, 2009.
3. Shoemarker M, Hamilton B, Dairkee SH, Cohen I and CampbellMJ: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 19: 649-651, 2005.
4. Massoud A, El Sisi S, Salama O and Massoud A: Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg65: 96-99, 2001.
5. Banno N, Akihisa T, Yasukawa K, et al: Anti-inflammatory activities of the triterpene acids from the resin of Boswelliacarteri. J Ethnopharmacol107: 249-253, 2006.
6. Chevrier MR, Ryan AE, Lee DY, et al: Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol12: 575-580, 2005.
7. Sharma ML, Khajuria A, Kaul A, et al: Effects of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leukocyte migration. Agents Actions24: 161-164, 1988.
8. Weckesser S, Engel K, Simon-Haarhaus B, et al: Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine14: 508-516, 2007.
9. O'Toole C, Price ZH, Ohnuki Y and Unsgaard B: Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38: 64-76, 1978.
10. Shen T and Lou HX: Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in chinese traditional medicine. Chem Biodivers5: 540-553, 2008.
11. de Rapper S, Van Vuuren SF, Kamatou GP, et al: The additive and synergistic antimicrobial effects of select frankincense and myrrh oils-a combination from the pharaonic pharmacopoeia. Lett Appl Microbiol 54: 352-358, 2012.
12. Chinese Pharmacopoeda Commission (eds): Appendix determination of volatile oil. In: Naphtha Measurement of Chinese Pharmacopeia. Vol 1. China Medical Science Press, Beijing, 2010.
13. Loewe S and Muischnek H: Effect of combinations: mathematical basis of the problem. Arch Exp Pathol Pharmacol 114: 313-326, 1926.
14. Mikhaeil BR, Maatoog GT, Badria FA and Amer MM: Chemistry and immunomodulatory activity of frankincense oil. Z Naturforsch C58: 230-238, 2003.
15. Tipton DA, Lyle B, Babich H and Dabbous MKh: In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro17: 301-310, 2003.
16. El Ashry ES, Rashed N, Salama OM and Saleh A: Components, therapeutic value and uses of myrrh. Pharmazie58: 163-168, 2003.
17. Shoemarker M, Hamilton B, Dairkee SH, Cohen I and CampbellMJ: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res19: 649-651, 2005.
18. Wu XS, Xie T, Lin J, et al: An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas. J Pharm Pharmacol61: 1653-1566, 2009.
19. Zhan YH, Liu J, Qu XJ, et al: β-Elemene induces apoptosis in human renal-cell carcinoma 786-0Cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways. Asian Pac J Cancer Prev13: 2739-2744, 2012.
20. Sun S, Du GJ, Qi LW, et al: Hydrophobic constituents and their potential anticancer activities from Devil's Club (Oplopanaxhorridus Miq.). J Ethnopharmacol132: 280-285, 2010.
21. Xu YT, Gu W, Liu JX, et al: D-limonene inhibits the proliferation of human bladder cancer cells and down-regulates the ras p21 expression. Zhonghua Bi Niao Wai Ke Za Zhi29: 808-810, 2008.
22. Huang JM, Tang XL, Huang L, et al: Influence of octanol protreatment on neuronal apoptosis and expression of glial fibrillary acidic protein in hippocampus in Kainic acid induced epileptic rats. J Clin Neurol6: 438-441, 2011 (In Chinese).
23. Afoulous S, Ferhout H, Raoelison EG, et al: Helichrysum gymnocephalum essential oil: chemical composition and cytotoxic, antimalarial and antioxidant activities, attribution of the activity origin by correlations. Molecules16: 8273-8291, 2011.